Airbus Quantum

Airbus is pioneering quantum computing applications in aerospace through strategic partnerships with Quantinuum, IonQ, and BMW Group to accelerate sustainable mobility research using cutting-edge quantum computers. The company launched the global Quantum Computing Challenge in 2024, attracting over 420 teams worldwide to develop quantum solutions for aviation and automotive challenges. Airbus focuses on quantum applications for hydrogen technology, fuel cell catalyst simulation, and secure communications infrastructure for aerospace platforms, investing through Airbus Ventures in quantum companies including IonQ, Q-CTRL, and QC Ware. The company collaborates with the University of Bristol’s Quantum Technology Innovation Centre and develops quantum-safe security technologies for aerospace applications, demonstrating quantum computing’s potential for solving computationally intensive tasks in sustainable aviation and ZEROe hydrogen-powered aircraft development.

Aqemia

Aqemia is a next-generation pharmatech company founded in 2019 as a deeptech spinoff from École Normale Supérieure that revolutionizes drug discovery by combining quantum-inspired physics algorithms with generative AI, enabling molecule exploration 10,000 times faster than conventional methods without requiring experimental training data. In 2024, Aqemia raised €60 million in Series A funding led by Cathay Innovation, bringing total funding to over €100 million, to prepare for clinical trials and fuel international expansion with a new London office opening in January 2025. The company currently has three cancer-targeting drug candidates undergoing preclinical animal testing, having progressed to this stage in under two years with expectations to move into clinical trials by 2025. Aqemia’s quantum-inspired algorithms simulate molecular behavior at unprecedented accuracy and speed, training AI models on physical laws governing molecular structures. Major partnerships include a $140 million collaboration with Sanofi and agreements with Servier and Johnson & Johnson to accelerate oncology drug development through physics-based molecular design.

BEIT

BEIT is an Israeli quantum computing applications company developing quantum solutions for cybersecurity, optimization, and enterprise applications in the Middle East and international markets. The company focuses on quantum algorithms for security applications, quantum-enhanced encryption systems, and quantum software solutions for government and enterprise customers seeking advanced computational capabilities. BEIT collaborates with Israeli defense and technology companies to develop quantum applications for national security, cybersecurity, and strategic computing applications, contributing to Israel’s quantum technology ecosystem and advancing practical quantum computing implementations for critical infrastructure protection and advanced analytics.

GSK Quantum

GlaxoSmithKline (GSK) is advancing quantum computing applications in pharmaceutical research through partnerships with IBM’s Quantum Heron and Condor processors for mRNA codon optimization and clinical data analysis, and collaboration with D-Wave for quantum annealing applications in genetic algorithms. The company worked with Capgemini UK and the National Quantum Computing Centre on quantum-enhanced drug discovery research, developing machine learning pipelines using quantum features for predicting targeted covalent drug reactivity. Led by Ross Walker, Global Director of Scientific Research Computing & Analytics, GSK participates in the QuPharm consortium alongside other major pharmaceutical companies to structure quantum computing’s potential in drug discovery, focusing on optimization problems that exceed traditional computational capabilities in messenger RNA research and therapeutic development.

Kvantify

Kvantify is a Danish quantum software company founded in 2022, developing quantum and high-performance computing solutions for businesses with a particular focus on drug discovery and pharmaceutical applications. The company creates software platforms that make quantum computing capabilities accessible to enterprises seeking to leverage quantum advantages for complex computational challenges in life sciences, molecular modeling, and optimization problems. Kvantify provides consulting services and develops custom quantum applications for pharmaceutical companies, biotech firms, and research institutions working on drug development, protein folding prediction, and chemical compound analysis. The company contributes to Denmark’s quantum technology ecosystem by advancing practical quantum software implementations for industrial applications and making quantum computing tools more accessible to businesses in the Nordic region.

Lockheed Martin Quantum

Lockheed Martin has been a pioneering customer and developer of quantum computing technology since becoming the first customer to purchase a D-Wave quantum computer in 2010 for optimization and machine learning applications in aerospace and defense. The company operates quantum computing research facilities and has integrated quantum technologies into various defense applications including secure communications, advanced radar systems, navigation, and cybersecurity solutions. Lockheed Martin collaborates with leading quantum companies and research institutions to develop quantum-enhanced capabilities for national security applications, investing in quantum sensing technologies for improved detection and measurement systems, quantum communications for secure military networks, and quantum computing applications for complex optimization problems in aircraft design, mission planning, and logistics coordination across their aerospace and defense portfolio.

Merck Quantum

Merck & Co. explores quantum computing applications for pharmaceutical research, focusing on quantum algorithms for drug discovery, molecular modeling, and clinical trial optimization to accelerate therapeutic development. The company investigates quantum machine learning for analyzing complex biological data, protein-drug interactions, and personalized medicine approaches that could enhance pharmaceutical research capabilities. Merck collaborates with quantum computing companies and research institutions to leverage quantum advantages in computational chemistry, vaccine development, and therapeutic optimization, exploring quantum technologies that could improve drug discovery processes, reduce development timelines, and enhance therapeutic efficacy across oncology, immunology, and infectious disease research programs for advancing global health outcomes.

Mode Labs

Mode Labs is a University of Oxford spin-out company founded in 2021, specializing in continuous, remote, real-time chemical sensors using quantum sensing technologies. The company develops advanced quantum sensing solutions for environmental monitoring, industrial process control, and chemical detection applications that require high precision and continuous operation. Mode Labs leverages quantum physics principles to create sensors with unprecedented sensitivity and accuracy for chemical analysis, gas detection, and environmental monitoring applications across various industries including pharmaceuticals, petrochemicals, environmental science, and industrial manufacturing. The company’s quantum sensing platform enables remote monitoring capabilities and real-time data collection for applications requiring continuous chemical analysis and environmental monitoring.

Novo Nordisk Quantum

Novo Nordisk explores quantum computing applications for pharmaceutical research and drug discovery, investigating quantum algorithms for molecular simulation, protein folding prediction, and drug optimization that could accelerate diabetes and obesity treatment development. The company researches quantum machine learning for analyzing clinical trial data, patient stratification, and personalized medicine approaches, exploring how quantum computing could enhance pharmaceutical research capabilities in endocrinology and metabolic diseases. Novo Nordisk collaborates with quantum computing companies and academic institutions to leverage quantum advantages in computational chemistry, biomarker discovery, and therapeutic development processes, contributing to the pharmaceutical industry’s adoption of quantum technologies for improving drug discovery timelines and therapeutic outcomes in diabetes care and chronic disease management.

Pfizer

Pfizer investigates quantum computing applications for pharmaceutical research and drug discovery, exploring quantum algorithms for molecular modeling, drug design optimization, and clinical trial analytics that could accelerate the development of new vaccines and therapeutic treatments, collaborating with quantum computing companies and academic institutions to leverage quantum simulation capabilities for understanding complex biological systems, protein interactions, and drug mechanisms of action, contributing to the pharmaceutical industry’s adoption of quantum technologies to enhance research productivity, reduce development costs, and improve patient outcomes through more effective drug discovery and personalized medicine approaches.

POLARISqb

POLARISqb is a US quantum biotechnology company founded in 2020 that applies quantum computing and quantum-inspired algorithms to accelerate drug discovery and development, using quantum molecular simulation and optimization techniques to identify novel drug candidates and optimize molecular properties more efficiently than classical computational methods, focusing on leveraging quantum advantage for pharmaceutical applications including drug design, molecular modeling, and therapeutic target identification to reduce drug development timelines and costs.

Quabacus

Quabacus is a quantum computing software company developing quantum algorithms and applications for complex optimization problems, focusing on quantum solutions for supply chain optimization, financial portfolio management, and resource allocation challenges. The company creates quantum software tools and consulting services for enterprises seeking to leverage quantum computing advantages in business optimization applications, working with Fortune 500 companies to implement quantum-enhanced solutions for logistics, scheduling, and decision-making processes. Quabacus provides quantum algorithm development services, quantum computing consulting, and hybrid classical-quantum optimization platforms that enable businesses to explore quantum computing benefits while integrating with existing enterprise systems and workflows.

Quantum-South

Quantum-South is a Uruguay-based quantum computing company founded in 2019, specializing in quantum applications for logistics optimization and financial modeling in Latin America. The company develops quantum algorithms and software solutions for complex optimization problems in supply chain management, portfolio optimization, risk analysis, and route optimization that can benefit from quantum computing advantages. Quantum-South provides quantum consulting services and develops quantum software applications tailored for Latin American markets, working with enterprises to implement quantum-enhanced solutions for business optimization challenges. The company represents one of the pioneering quantum technology companies in Latin America, contributing to the region’s quantum computing ecosystem by advancing practical quantum applications in finance and logistics while building quantum expertise and capabilities in Uruguay and broader Latin American markets.

Qubit Pharmaceuticals

Qubit Pharmaceuticals is a Paris and Boston-based quantum-enhanced drug discovery company founded in 2020 that accelerates pharmaceutical research using hybrid quantum-classical computing through their Atlas platform, achieving molecular simulations 100,000 times faster than traditional methods while reducing drug candidate screening from 5,000 to 200 compounds, with breakthrough technologies including the Hyperion-1 quantum emulator simulating 40 qubits and the FeNNix-Bio1 quantum AI foundation model developed with Sorbonne University, operating one of France’s largest GPU supercomputers and advancing 7 therapeutic programs particularly in oncology and inflammation.

Roche

Roche explores quantum computing applications for pharmaceutical research and drug discovery, investigating quantum algorithms for molecular simulation, protein folding prediction, and drug-target interaction modeling that could accelerate the development of new medicines and personalized therapies, collaborating with quantum computing companies and research institutions to leverage quantum advantages in computational chemistry, clinical trial optimization, and biomarker discovery, exploring how quantum machine learning and quantum simulation could enhance pharmaceutical research capabilities and reduce drug development timelines while improving therapeutic outcomes for patients across oncology, immunology, and other therapeutic areas.

Rolls-Royce

Rolls-Royce explores quantum computing applications for aerospace and energy sectors, investigating quantum algorithms for engine design optimization, materials simulation, supply chain management, and predictive maintenance to enhance efficiency and performance in aviation and power generation systems.

Company Information

• Founded: 2021
• Country: UK
• Website: https://rolls-royce.com
• Categories: applications

Key People

Unknown

Related Companies

Explore other quantum computing companies in similar categories or regions.

← Back to All Companies

Shell

Shell investigates quantum computing applications for energy optimization and oil & gas operations, exploring quantum algorithms for reservoir simulation, molecular modeling for catalyst design, logistics optimization, and energy trading to improve efficiency and reduce environmental impact in energy production and distribution.

Company Information

• Founded: 2020
• Country: Netherlands
• Website: https://shell.com
• Categories: applications

Key People

Unknown

Related Companies

Explore other quantum computing companies in similar categories or regions.

← Back to All Companies

TotalEnergies

TotalEnergies explores quantum computing applications for energy sector optimization and sustainability initiatives, investigating quantum algorithms for renewable energy grid optimization, carbon capture simulation, oil reservoir modeling, and energy trading strategies, collaborating with quantum computing companies and research institutions to develop quantum solutions for complex energy challenges including molecular simulation for battery materials, catalyst design for cleaner energy production, and optimization of energy distribution networks, contributing to the energy industry’s digital transformation through quantum-enhanced modeling and optimization capabilities that could improve energy efficiency and accelerate the transition to sustainable energy systems.

Volkswagen

Volkswagen is a German automotive company that pioneered quantum computing applications in the automotive industry, developing quantum algorithms for traffic flow optimization, route optimization, and autonomous vehicle coordination using D-Wave quantum annealing systems to optimize taxi routing in major cities, investigating quantum machine learning for predictive maintenance, battery optimization for electric vehicles, and supply chain management, collaborating with quantum computing companies to explore quantum advantages in manufacturing optimization, materials simulation for vehicle design, and logistics coordination across their global automotive production and distribution network.